Epstein Becker Green’s Amy Dow Named to Law360 Life Sciences Editorial Advisory BoardFebruary 26, 2016
CHICAGO, IL (February 26, 2016) – Epstein Becker Green is pleased to announce that Law360 has selected Amy K. Dow to serve for a second consecutive year on the publication’s Life Sciences editorial advisory board for 2016.
According to Law360, “the purpose of the editorial advisory board is to get feedback on Law360's coverage and to gain insight from experts in the field on how best to shape future coverage.”
Ms. Dow is a member in Epstein Becker Green's health care and life sciences practice in the firm's Chicago office. She primarily represents pharmaceutical, medical device and biologics manufacturers in U.S. Food and Drug Administration regulatory, fraud and abuse and transactional matters. Ms. Dow also provides health regulatory due diligence services to private equity firms and other investors in life sciences sector entities.
About Epstein Becker Green
Epstein Becker & Green P.C., is a national law firm with a primary focus on health care and life sciences; employment, labor, and workforce management; and litigation and business disputes. Founded in 1973 as an industry-focused firm, Epstein Becker Green has decades of experience serving clients in health care, financial services, retail, hospitality, and technology, among other industries, representing entities from startups to Fortune 100 companies. Operating in offices throughout the U.S. and supporting clients in the U.S. and abroad, the firm’s attorneys are committed to uncompromising client service and legal excellence. For more information, visit www.ebglaw.com.